Polymorphisms in the human glutathione transferase zeta promoter

Pharmacogenetics and Genomics

Volumn 16, Issue 5, 2006, Pages 307-313

  Fang, Yu Yan ^a   Kashkarov, Uliana ^a   Anders, M W ^b   Board, Philip G ^a  

^a Australian National University   (Australia)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Glutathione transferase zeta; Gstz1 expression; Promoter polymorphism

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE Z1; HOMEODOMAIN PROTEIN; LUCIFERASE; PROTEIN MYB; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; GENES, REPORTER; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; LUCIFERASES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION INITIATION SITE;

EID: 33645934526     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/01.fpc.0000205000.07054.b3     Document Type: Article

References (33)

1. Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 1997; 328:929-935.
2. Tong Z, Board PG, Anders MW. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol 1998; 11:1332-1338.
3. Fernandez-Canon JM, Penalva MA. Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J Biol Chem 1998; 273:329-337.
4. Bull RJ, Sanchez IM, Nelson MA, Larson JL, Lansing AJ. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 1990; 63:341-359.
5. DeAngelo AB, Daniel FB, Most BM, Olson GR. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 1996; 114: 207-221.
6. Harrington-Brock K, Doerr CL, Moore MM. Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells. Mutat Res 1998; 413:265-276.
7. Krasner SW, McGuire MJ, Jacangelo JG, Patania NL, Reagan KM, Aieta EM. The occurence of disinfection by-products in US drinking water. J Am Waterworks Assoc 1989; 81:41-53.
8. Stacpoole PW, Henderson GN, Yan Z, James MO. Clinical pharmacology and toxicology of dichloroacetate. Environ Health Perspect 1998; 106 (Suppl 4):989-994.
9. Stacpoole PW, Henderson GN, Yan Z, Cornett R, James MO. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev 1998; 30:499-539.
10. Tzeng HF, Blackburn AC, Board PG, Anders MW. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol 2000; 13:231-236.
11. Mitchell GA, Grompe M, Lambert M, Tanquay RM. Hypertyrosiemia. New York: McGraw-Hill, 2001. pp. 1777-1805.
12. Fernandez-Canon JM, Baetscher MW, Finegold M, Burlingame T, Gibson KM, Grompe M. Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol Cell Biol 2002; 22:4943-4951.
13. Lim CE, Matthaei KI, Blackburn AC, Davis RP, Dahlstrom JE, Koina ME, Anders MW, Board PG. Mice deficient in glutathione transferase zeta/ maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol 2004; 165:679-693.
14. Blackburn AC, Matthaei KI, Lim CE, Taylor MC, Cappello JY, Hayes JD, Anders MW, Board PG. Deficiency of glutathione transferase Zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol 2006; 69:650-657.
15. Blackburn AC, Coggan M, Tzeng HF, Lantum H, Polekhina G, Parker MW, Anders MW, Board PG. GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics 2001; 11: 671-678.
16. Bert AG, Burrows J, Osborne CS, Cockerill PN. Generation of an improved luciferase reporter gene plasmid that employs a novel mechanism for high-copy replication. Plasmid 2000; 44:173-182.
17. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-4884.
18. Weston K. Myb proteins in life, death and differentiation. Curr Opin Genet Dev 1998; 8:76-81.
19. Opstelten DJ, Vogels R, Robert B, Kalkhoven E, Zwartkruis F, de Laaf L, et al. The mouse homeobox gene, S8, is expressed during embryogenesis predominantly in mesenchyme. Mech Dev 1991; 34:29-41.
20. Gehring WJ, Affolter M, Burglin T. Homeodomain proteins. Annu Rev Biochem 1994; 63:487-526.
21. Galliot B, de Vargas C, Miller D. Evolution of homeobox genes: Q50 Paired-like genes founded the Paired class. Dev Genes Evol 1999; 209:186-197.
22. Leussink B, Brouwer A, el Khattabi M, Poelmann RE, Gittenberger-de Groot AC, Meijlink F. Expression patterns of the paired-related homeobox genes MHox/Prx1 and S8/Prx2 suggest roles in development of the heart and the forebrain. Mech Dev 1995; 52:51-64.
23. Chesterman ES, Kern MJ. Comparative analysis of Prx1 and Prx2 expression in mice provides evidence for incomplete compensation. Anat Rec 2002; 266:1-4.
24. Cserjesi P, Lilly B, Bryson L, Wang Y, Sassoon DA, Olson EN. MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development 1992; 115: 1087-1101.
25. Khachigian LM, Lindner V, Williams AJ, Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 1996; 271:1427-1431.
26. Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 53:37-43.
27. Parks CL, Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 1996; 271: 4417-4430.
28. Parks CL, Shenk T. Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1. J Virol 1997; 71: 9600-9607.
29. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, et al. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 1999; 274:3076-3093.
30. Her S, Bell RA, Bloom AK, Siddall BJ, Wong DL. Phenylethanolamine N-methyltransferase gene expression. Sp1 and MAZ potential for tissue-specific expression. J Biol Chem 1999; 274:8698-8707.
31. Lee S, Park U, Lee YI. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 2001; 283:167-177.
32. James MO, Cornett R, Yan Z, Henderson GN, Stacpoole PW. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation, in hepatic cytosol from humans and rats is reduced in dichloroacetate-treated rats. Drug Metab Dispos 1997; 25:1223-1227.
33. Anderson WB, Board PG, Gargano B, Anders MW. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids. Chem Res Toxicol 1999; 12:1144-1149.